乌比基特异蛋白酶46在神经系统和癌症中的结构,抑制剂和生物功能
Khanh Huyen Thi Pham1,2, Manh Hung Tran1, Le Ba Nam3
1Department of Pharmacy, School of Medicine and Pharmacy, The University of Danang, Danang City, Vietnam.
Bioinformatics and biology insights
|October 16, 2024
概括
乌比奎特异性蛋白酶46 (USP46) 是一种在细胞生物学和疾病中至关重要的双化酶 (DUB). 新兴研究突出显示 USP46
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 脱化酶 (DUBs) 调节了泛化,影响了癌症和神经退行等疾病途径.
- 一个著名的DUB,USP46,在各种生物过程中发挥作用,越来越多的证据将其与癌症联系起来.
- 由于其活性位点,DUBs是小分子药物开发的有吸引力的目标.
研究的目的:
- 提供对Ubiquitin特异性蛋白酶46 (USP46) 的全面审查.
- 总结关于USP46的特征,结构和抑制剂的当前知识.
- 探索USP46在疾病中的作用,特别是神经系统的疾病及其与癌症的相关性.
主要方法:
- 关于USP46.6的现有研究的文献综述.
- 分析USP46的生物化学特性和结构特征.
- 关于USP46在疾病发病过程中的参与数据的综合.
主要成果:
- USP46有一个明确的活性部位,使其成为潜在的药物目标.
- 最近的研究越来越多地揭示了USP46在癌症发展中的重要作用.
- 目前正在积极研究USP46在神经系统和其他疾病中的功能.
结论:
- USP46 是一种关键的二基化酶,对各种疾病,尤其是癌症有影响.
- 进一步研究USP46抑制剂及其在疾病中的精确作用是有必要的.
- USP46代表了癌症和神经系统疾病治疗干预的有希望的目标.
相关概念视频
The Proteasome
816
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
816
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K


